ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $22,451,000 | +4.8% | 379,682 | -13.8% | 0.08% | -1.2% |
| Q3 2020 | $21,423,000 | -4.5% | 440,539 | -5.0% | 0.09% | -13.1% |
| Q2 2020 | $22,426,000 | +8.5% | 463,539 | -37.7% | 0.10% | -22.0% |
| Q1 2020 | $20,661,000 | -38.1% | 743,734 | -33.3% | 0.13% | -28.2% |
| Q4 2019 | $33,373,000 | -7.3% | 1,115,411 | -4.3% | 0.18% | -27.8% |
| Q3 2019 | $36,011,000 | -36.0% | 1,165,411 | 0.0% | 0.24% | -36.0% |
| Q2 2019 | $56,289,000 | – | 1,165,411 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |